NCT02365103

Brief Summary

The purpose of this study is to investigate the inhibition effect of tea consumption on non haem iron absorption with the use of an iron tracer. The study also aims to assess the effect of time variability of tea consumption on non haem iron absorption from a typical western breakfast.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 18, 2015

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

May 23, 2019

Status Verified

May 1, 2019

Enrollment Period

4 months

First QC Date

February 4, 2015

Last Update Submit

May 21, 2019

Conditions

Keywords

Anemia, Iron-DeficiencyIron, BioavailabilityHepcidinsIntestinal, AbsorptionIsotope Labeling, Stable

Outcome Measures

Primary Outcomes (1)

  • Iron absorption (%) measured by mass spectrometer

    Iron absorption is estimated based on the erythrocyte iron incorporation to the body system with the use of iron tracer after 14 days following administration of the test meals

    14 days after each test meal

Secondary Outcomes (8)

  • Serum ferritin measured by Biomerieux mini VIDAS

    1 year

  • Hepcidin measured by enzyme-linked immunosorbent assay (ELISA) kit

    1 year

  • Full blood count measured by Beckman Coulter Counter

    1 year

  • Zinc protoporphyrin (ZPP) measured by haemato-fluorimetry

    1 year

  • Total binding iron capacity (TIBC) measured by enzyme-linked immunosorbent assay (ELISA) kit

    1 year

  • +3 more secondary outcomes

Study Arms (4)

Test meal I (given with water)

OTHER

Test meal with water

Other: Test meal I (given with water)

Test meal II (simultaneously with tea)

OTHER

Test meal with tea (simultaneously)

Other: Test meal II (simultaneously with tea)

Test meal III (1 hour after test meal)

OTHER

Test Meal with tea given 1 hour after test meal

Other: Test meal III (1 hour after test meal)

Reference Iron Dose

OTHER

Reference iron dose administered

Other: Reference iron dose

Interventions

4 mg of the iron stable isotope, in a form of ferrous sulphate solution, extrinsically labelled in the test meal administered in the study, enrichment in the system will take approximately 14 days post dosing

Test meal I (given with water)

4 mg of the iron stable isotope, in a form of ferrous sulphate solution, extrinsically labelled in the test meal administered in the study, enrichment in the system will take approximately 14 days post dosing

Test meal II (simultaneously with tea)

4 mg of the iron stable isotope, in a form of ferrous sulphate solution, extrinsically labelled in the test meal administered in the study, enrichment in the system will take approximately 14 days post dosing

Test meal III (1 hour after test meal)

3 mg of the iron stable isotope, in a form of ferrous sulphate solution, extrinsically labelled and administered in the study, enrichment in the system will take approximately 14 days post dosing

Reference Iron Dose

Eligibility Criteria

Age19 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • pre menopausal women;
  • aged 19- 40 years;
  • healthy;
  • non- pregnant nor lactating.

You may not qualify if:

  • history of gastrointestinal and metabolic disorders;
  • have donated blood within past 6 months;
  • regularly consuming nutritional supplements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chester

Chester, Cheshire, CH1 4BJ, United Kingdom

Location

Related Publications (1)

  • Ahmad Fuzi SF, Koller D, Bruggraber S, Pereira DI, Dainty JR, Mushtaq S. A 1-h time interval between a meal containing iron and consumption of tea attenuates the inhibitory effects on iron absorption: a controlled trial in a cohort of healthy UK women using a stable iron isotope. Am J Clin Nutr. 2017 Dec;106(6):1413-1421. doi: 10.3945/ajcn.117.161364. Epub 2017 Oct 18.

    PMID: 29046302BACKGROUND

MeSH Terms

Conditions

Anemia, Iron-Deficiency

Interventions

WaterTea

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen CompoundsPlant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Sohail Mushtaq, PhD

    University of Chester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2015

First Posted

February 18, 2015

Study Start

November 1, 2014

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

May 23, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

The results are in the writing phase, and will be available in thesis form and possibly publication. It will be available in thesis form in 2017 and publication expected to be in 2018.

Locations